Advancing Therapeutic Protein Production With Real-Time Analysis

Real-Time Decisions in Therapeutic Protein Manufacturing with Process Raman Analyzer Advancing Therapeutic Protein Production With Real-Time Analysis Accurate protein quantification post-clarification and purification, real-time excipient monitoring during ultrafiltration/diafiltration (UF/DF), and insights for process optimization are among the many ways Raman spectroscopy delivers impact. As a process analytical technology (PAT), it enables precise, specific, and non-destructive in-line monitoring and control—streamlining operations, reducing costs, and minimizing offline analyses. This webinar will explore how a process Raman analyzer supports these applications, enhances process understanding in therapeutic protein production, and advances automation in modern biomanufacturing. Therapeutic protein manufacturing faces challenges in maintaining efficiency, reducing costs and ensuring consistent quality while minimizing offline testing. Join our speaker as she discusses how precise, non-destructive, real-time insights into protein production and biomanufacturing helps teams make faster, data-driven decisions. This webinar will share how in-line monitoring can strengthen process understanding, support continuous control strategies and accelerate automation – advancing modern therapeutic protein manufacturing from upstream to downstream operations. Attend this webinar to: 1. Understand how Process Raman supports automation in biomanufacturing 2. Explore practical applications such as protein quantification during clarified harvest and excipient monitoring during ultrafiltration/diafiltration, integrating process control 3. Learn how to leverage data-rich insights to optimize workflows, enhance process understanding and address modern biomanufacturing challenges Name Michelle Nolasco Job title/position Systems Design Engineer Company/affiliation Thermo Fisher Scientific Speaker’s email address michelle.nolasco@thermofisher.com Biography Michelle Nolasco leads innovation initiatives and collaborations for bioproduction at Thermo Fisher Scientific. Michelle specializes in downstream processes and has experience in automation and advanced analytics. Prior to her current role, Michelle was part of the downstream process development team at Patheon Biologics, supporting development and clinical manufacturing for monoclonal antibodies and recombinant enzymes. Michelle holds a bachelor’s degree in chemical engineering from the University of South Florida. https://www.linkedin.com/in/michelle-nolasco-090130b3/ Thermo Fisher Scientific Technology Networks